PMA device
Silicone Stimulation Lead, Silicone Sensing Lead
Inspire Medical Systems · Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ, Class III) · First FDA decision Apr 29, 2022, newest Apr 29, 2022Sleep apnea
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
773
Naming "Silicone"
MAUDE reports
0
Brand "Silicone", since 2015
PubMed studies
40,305
Mentioning "Silicone"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Silicone Stimulation Lead, Silicone Sensing Lead
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38528WPS Insurance CorporationUpdated Mar 20, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38307CGS Administrators, LLCUpdated Feb 27, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38310Noridian Healthcare Solutions, LLCUpdated Oct 16, 2025
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38398First Coast Service Options, Inc.Updated Jan 24, 2020
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38385Novitas Solutions, Inc.Updated Jan 24, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Silicone", any status and sponsor, newest update first.
Unicon Optical Co. Ltd.Not on our public-company list
NCT07322211 · 35 participants · Start Jan 20, 2026 · Primary completion Jun 18, 2026
Device: Treatment · For: Refractive Ametropia
Sites: Kaohsiung City, Taiwan; Taoyuan, Taiwan
University of PaviaAcademic, hospital or other
NCT07491536 · 40 participants · Start Mar 1, 2026 · Primary completion Nov 1, 2026
Device: Gas Ozone Therapy · For: Oral Mucositis; Chemotherapy-induced Oral Mucositis; Head and Neck Neoplasms
Sites: Pavia, Italy
University of MichiganAcademic, hospital or other
NCT07191314 · 20 participants (planned) · Start Oct 21, 2025 · Primary completion Sep 2027
Device: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device · For: Sleep Apnea, Obstructive
Sites: Ann Arbor, Michigan · 2 sites in all
770 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Silicone", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MNQ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Silicone"[tiab]. The summary above synthesizes these.
- Silicone in Dermatology: An Update.
Bains P, Kaur S · J Cutan Aesthet Surg · 2023Review
- Vulvar Silicone Granuloma.
Guerrieri C, Hudacko R, Joseph EM · Int J Gynecol Pathol · 2020Case Reports
- STICKY SILICONE OIL.
Ghoraba HH, Zaky AG, Abd Al Fatah HM, et al. · Retina · 2017
- Silicone toxicology.
Busch H · Semin Arthritis Rheum · 1994Review
- Silicone granuloma.
Krayenbühl BH, Panizzon RG · Dermatology · 2000Case Reports
- Recognizing intraventricular silicone.
Mayl JJ, Flores MA, Stelzer JW, et al. · Emerg Radiol · 2018Case Reports
- Augmentation Rhinoplasty Using Silicone Implants.
Kim IS · Facial Plast Surg Clin North Am · 2018Review
- Intraventricular silicone oil.
Chang CC, Chang HS, Toh CH · J Neurosurg · 2013Case Reports
- Reimagining silicone's life cycle.
Ghosh K · Science · 2025
- Silicone breast implants may contribute to early-onset fetal growth restriction.
Hoirisch-Clapauch S · Clin Rheumatol · 2023
- Use of custom silicone putty for nasal tube stabilisation in orthognathic surgery.
Adam M, Chiu G · Br J Oral Maxillofac Surg · 2023
Other devices of this type
Also filed under product code MNQ.
- Inspire II Upper Airway StimulatorInspire Medical Systems · PMA 2026
- Inspire® Upper Airway StimulationInspire Medical Systems · PMA 2025
- aura6000 systemLivaNova USA, Inc. · PMA 2026
- Genio® System 2.1Nyxoah S.A. · PMA 2025
- Inspire UAS High AHI/High BMIInspire Medical Systems · PMA 2023
- SleepSync ProgrammerInspire Medical Systems · PMA 2023
- Inspire Medical Systems, Model 2580 Patient ProgrammerInspire Medical Systems · PMA 2021
- Inspire Programmer SystemInspire Medical Systems · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.